SLDB Solid Biosciences Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $733.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $59.0K |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $14.7K |
| 2023-Q2 | $0 | $2.4K |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $82.8K |
| 2024-Q1 | $23.9M | $39.4K |
| 2024-Q2 | $8.4K | $4.8K |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $151.0K |
| 2025-Q1 | $26.1M | $142.9K |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $147.9K |
| 2026-Q1 | $0 | $2.5M |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $24.6K |
Bought$50.0M7 buy days
Sold$3.2M59 sell days
Net insider flow+$46.8Mnet buying · 5 years
Latest trade2026-10-19Brooks Gabriel
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Sell | Brooks Gabriel | Other C-suite | 4,374 | $5.62 | $24.6K | 1 |
| 2026-02-18 | Sell | Cumbo Alexander | CEO | 16,644 | $5.82 | $96.9K | 1 |
| 2026-02-18 | Sell | Howton David T | COO | 7,469 | $5.82 | $43.5K | 1 |
| 2026-02-18 | Sell | Tan Kevin | CFO | 5,404 | $5.82 | $31.5K | 1 |
| 2026-02-18 | Sell | Hanrahan Jessie | Other C-suite | 4,134 | $5.82 | $24.1K | 1 |
| 2026-02-18 | Sell | Herzich Paul | Other C-suite | 3,616 | $5.82 | $21.0K | 1 |
| 2026-02-18 | Sell | Ganot Ilan | Director | 2,658 | $5.82 | $15.5K | 1 |
| 2026-02-04 | Sell | Cumbo Alexander | CEO | 48,913 | $6.44 | $315.0K | 1 |
| 2026-02-04 | Sell | Howton David T | COO | 18,894 | $6.44 | $121.7K | 1 |
| 2026-02-04 | Sell | Tan Kevin | CFO | 14,783 | $6.44 | $95.2K | 1 |
| 2026-02-04 | Sell | Brooks Gabriel | Other C-suite | 12,616 | $6.44 | $81.2K | 1 |
| 2026-02-04 | Sell | Hanrahan Jessie | Other C-suite | 12,348 | $6.44 | $79.5K | 1 |
| 2026-02-04 | Sell | Herzich Paul | Other C-suite | 10,905 | $6.44 | $70.2K | 1 |
| 2026-02-04 | Sell | Ganot Ilan | Director | 7,205 | $6.44 | $46.4K | 1 |
| 2026-02-02 | Sell | Cumbo Alexander | CEO | 80,258 | $6.44 | $516.9K | 1 |
| 2026-02-02 | Sell | Howton David T | COO | 37,771 | $6.44 | $243.2K | 1 |
| 2026-02-02 | Sell | Brooks Gabriel | Other C-suite | 28,335 | $6.44 | $182.5K | 1 |
| 2026-02-02 | Sell | Tan Kevin | CFO | 26,837 | $6.44 | $172.8K | 1 |
| 2026-02-02 | Sell | Hanrahan Jessie | Other C-suite | 26,535 | $6.44 | $170.9K | 1 |
| 2026-02-02 | Sell | Herzich Paul | Other C-suite | 26,250 | $6.44 | $169.0K | 1 |
| 2026-01-28 | Sell | Ganot Ilan | Director | 191 | $6.59 | $1.3K | 1 |
| 2026-01-13 | Sell | Tan Kevin | CFO | 5,704 | $5.27 | $30.1K | 1 |
| 2026-01-05 | Sell | Ganot Ilan | Director | 1,053 | $5.43 | $5.7K | 1 |
| 2025-12-03 | Sell | Cumbo Alexander | CEO | 10,808 | $5.11 | $55.2K | 1 |
| 2025-12-03 | Sell | Howton David T | COO | 4,932 | $5.11 | $25.2K | 1 |
| 2025-12-03 | Sell | Hanrahan Jessie | Other C-suite | 4,483 | $5.11 | $22.9K | 1 |
| 2025-12-03 | Sell | Herzich Paul | Other C-suite | 2,701 | $5.11 | $13.8K | 1 |
| 2025-11-10 | Sell | Ganot Ilan | Director | 3,278 | $4.12 | $13.5K | 1 |
| 2025-10-20 | Sell | Brooks Gabriel | Other C-suite | 2,895 | $5.96 | $17.3K | 1 |
| 2025-03-11 | Buy | Kahn Clare | Director | 1,860 | $5.34 | $9.9K | 1 |
| 2025-02-19 | Buy | EDELMAN JOSEPH | Director | 5,000,000 | $4.03 | $20.2M | 1 |
| 2025-02-19 | Buy | BCIP Life Sciences Associates, LP | 10% owner | 1,000,000 | $4.03 | $4.0M | 1 |
| 2025-02-18 | Buy | Atchinson Robert | 10% owner | 252,545 | $7.56 | $1.9M | 1 |
| 2025-02-14 | Sell | Cumbo Alexander | CEO | 11,365 | $3.96 | $45.0K | 1 |
| 2025-02-14 | Sell | Howton David T | COO | 5,561 | $3.96 | $22.0K | 1 |
| 2025-02-14 | Sell | Brooks Gabriel | Other C-suite | 3,256 | $3.96 | $12.9K | 1 |
| 2025-02-14 | Sell | Tan Kevin | CFO | 3,164 | $3.96 | $12.5K | 1 |
| 2025-02-14 | Sell | Hanrahan Jessie | Other C-suite | 3,079 | $3.96 | $12.2K | 1 |
| 2025-02-14 | Sell | Herzich Paul | Other C-suite | 2,688 | $3.96 | $10.6K | 1 |
| 2025-02-14 | Sell | Ganot Ilan | Director | 1,711 | $3.96 | $6.8K | 1 |
| 2025-01-28 | Sell | Ganot Ilan | Director | 144 | $3.11 | $448 | 1 |
| 2025-01-10 | Sell | Tan Kevin | CFO | 4,073 | $3.89 | $15.8K | 1 |
| 2025-01-06 | Sell | Ganot Ilan | Director | 1,056 | $4.31 | $4.6K | 1 |
| 2024-12-03 | Sell | Cumbo Alexander | CEO | 11,114 | $5.60 | $62.2K | 1 |
| 2024-12-03 | Sell | Howton David T | COO | 5,072 | $5.60 | $28.4K | 1 |
| 2024-12-03 | Sell | Hanrahan Jessie | Other C-suite | 4,610 | $5.60 | $25.8K | 1 |
| 2024-12-03 | Sell | Herzich Paul | Other C-suite | 2,777 | $5.60 | $15.6K | 1 |
| 2024-10-21 | Sell | Brooks Gabriel | Other C-suite | 2,923 | $6.50 | $19.0K | 1 |
| 2024-06-07 | Buy | Kahn Clare | Director | 1,100 | $7.67 | $8.4K | 1 |
| 2024-05-02 | Sell | Ganot Ilan | Director | 462 | $10.33 | $4.8K | 1 |
| 2024-01-29 | Sell | Ganot Ilan | Director | 139 | $7.99 | $1.1K | 1 |
| 2024-01-11 | Buy | EDELMAN JOSEPH | Director | 3,410,713 | $5.53 | $18.9M | 1 |
| 2024-01-11 | Buy | Kolchinsky Peter | Director | 904,160 | $5.53 | $5.0M | 1 |
| 2024-01-09 | Sell | Tan Kevin | CFO | 3,935 | $8.20 | $32.3K | 1 |
| 2024-01-03 | Sell | Ganot Ilan | Director | 1,142 | $5.30 | $6.1K | 1 |
| 2023-12-04 | Sell | Cumbo Alexander | CEO | 11,757 | $2.77 | $32.6K | 1 |
| 2023-12-04 | Sell | Howton David T | COO | 5,367 | $2.78 | $14.9K | 1 |
| 2023-12-04 | Sell | Hanrahan Jessie | Other C-suite | 4,879 | $2.78 | $13.6K | 1 |
| 2023-12-04 | Sell | Marlowe Jennifer | Other C-suite | 4,890 | $2.77 | $13.5K | 1 |
| 2023-12-04 | Sell | Herzich Paul | Other C-suite | 2,968 | $2.77 | $8.2K | 1 |
| 2023-05-02 | Sell | Ganot Ilan | Director | 487 | $4.85 | $2.4K | 1 |
| 2023-01-27 | Sell | Ganot Ilan | Director | 1,523 | $7.49 | $11.4K | 2 |
| 2023-01-27 | Sell | Morris Carl Ashley | Other C-suite | 441 | $7.49 | $3.3K | 1 |
| 2022-03-14 | Sell | Schneider Joel Solomon Zev | COO | 30,504 | $1.10 | $33.6K | 2 |
| 2022-03-14 | Sell | Morris Carl Ashley | Other C-suite | 22,665 | $1.10 | $24.9K | 2 |
| 2022-02-10 | Sell | Ganot Ilan | CEO | 463 | $1.12 | $519 | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| EDELMAN JOSEPH | Director | $39.0M | $0 | 2025-02-19 |
| Kolchinsky Peter | Director | $5.0M | $0 | 2024-01-11 |
| BCIP Life Sciences Associates, LP | 10% owner | $4.0M | $0 | 2025-02-19 |
| Atchinson Robert | 10% owner | $1.9M | $0 | 2025-02-18 |
| Cumbo Alexander | CEO | $0 | $1.1M | 2026-02-18 |
| Howton David T | COO | $0 | $498.9K | 2026-02-18 |
| Tan Kevin | CFO | $0 | $390.2K | 2026-02-18 |
| Hanrahan Jessie | Other C-suite | $0 | $348.9K | 2026-02-18 |
| Brooks Gabriel | Other C-suite | $0 | $337.5K | 2026-10-19 |
| Herzich Paul | Other C-suite | $0 | $308.5K | 2026-02-18 |
| Ganot Ilan | Director | $0 | $120.3K | 2026-02-18 |
| Schneider Joel Solomon Zev | COO | $0 | $33.6K | 2022-03-14 |
| Morris Carl Ashley | Other C-suite | $0 | $28.2K | 2023-01-27 |
| Kahn Clare | Director | $18.4K | $0 | 2025-03-11 |
| Marlowe Jennifer | Other C-suite | $0 | $13.5K | 2023-12-04 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-02-18 → 2025-03-11 | 4 | $26.1M | 59 | -20.6% (-25.4% raw) | -46.1% (-53.3% raw) | -13.7% (-7.0% raw) | closed |
| 2018-01-30 | 3 | $37.3M | 44 | +14.0% (+11.5% raw) | -30.7% (-35.1% raw) | +34.8% (+37.2% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.